NeuroVasc Technologies is a private company founded in 2015 and dedicated to advancing neurovascular innovation. Unlike other start-ups, NeuroVasc's efforts are not just to develop a single product or single family of products, but to assemble a leading catalogue of products-internally developed and acquired-to address unmet needs in the treatment of neurovascular disease. Its current core product is a next-generation mechanical thrombectomy system that is designed to improve physicians' clot retrieval capabilities in tortuous anatomy. NeuroVasc has received a CE Mark and is commercially active in Europe and Hong Kong, with 2020 commercial sales activity planned to expand into South America and Southeast Asia.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/27/20 | $34,000,000 | Strategic |
Wego Group | undisclosed |
